參考文獻

8-22

1. Miller WR. Motivational interviewing: research, practice, and puzzles. Addictive behaviors 1996 Nov-Dec;21(6):835-842.

2. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. The American psychologist 1992 Sep;47(9):1102-1114.

3. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive behaviors 2012 Jan;37(1):11-24.

4. Hendershot CS, Witkiewitz K, George WH, Marlatt GA. Relapse prevention for addictive behaviors. Substance abuse treatment, prevention, and policy 2011;6:17.

5. Marlatt GA, George WH. Relapse prevention: introduction and overview of the model. British journal of addiction 1984 Sep;79(3):261-273.

  1. Najavits LM, Weiss RD. The role of psychotherapy in the treatment of substance- use disorders. Harvard review of psychiatry 1994 Jul-Aug;2(2):84-96.

  2. Graham K, Annis HM, Brett PJ, Venesoen P. A controlled field trial of group versus individual cognitive-behavioural training for relapse prevention. Addiction 1996 Aug;91(8):1127-1139.

  3. Morgan CJ, Curran HV. Ketamine use: a review. Addiction 2012 Jan;107(1):27-38.

  4. Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction 2009 Jan;104(1):77-87.

  5. Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010 Jan;105(1):121-133.

  6. Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 2008 Jun 1;95(3):219-229.

  7. Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J 2010 Feb;16(1):6-11.

  8. Weiner AL, Vieira L, McKay CA, Bayer MJ. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med 2000 May;18(4):447-451.

  9. Wolff K, Winstock AR. Ketamine : from medicine to misuse. CNS Drugs 2006;20(3):199-218.

  10. Critchlow DG. A case of ketamine dependence with discontinuation symptoms. Addiction 2006 Aug;101(8):1212-1213.

  11. Curran HV, Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 2001 May;96(5):749-760.

  12. Chen WJ, Fu TC, Ting TT, et al. Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006. BMC Public Health 2009;9:27.

  13. Chu PS, Ma WK, Wong SC, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 2008 Dec;102(11):1616-1622.

  14. Gutkin E, Hussain SA, Kim SH. Ketamine-Induced Biliary Dilatation: From Hong Kong to New York. J Addict Med 2011 Nov 24.

  15. Jansen KL. A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs 2000 Oct-Dec;32(4):419-433.

  16. Jansen KL, Darracot-Cankovic R. The nonmedical use of ketamine, part two: A review of problem use and dependence. J Psychoactive Drugs 2001 Apr-Jun;33(2):151-158.

  17. Mason K, Cottrell AM, Corrigan AG, Gillatt DA, Mitchelmore AE. Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol 2010 Oct;65(10):795-800.